25 Disorders of Proline and Serine Metabolism

Total Page:16

File Type:pdf, Size:1020Kb

25 Disorders of Proline and Serine Metabolism 25 Disorders of Proline and Serine Metabolism Jaak Jaeken 25.1 Inborn Errors of Proline Metabolism – 317 25.1.1 Proline Oxidase Deficiency (Hyperprolinemia Type I) – 317 25.1.2 ∆1-Pyrroline 5-Carboxylate Dehydrogenase Deficiency (Hyperprolinemia Type II) – 317 25.2 Inborn Errors of Serine Metabolism – 318 25.2.1 3-Phosphoglycerate Dehydrogenase Deficiency – 318 25.2.2 Phosphoserine Phosphatase Deficiency – 318 25.2.3 Serine Deficiency with Ichthyosis and Polyneuropathy – 318 References – 319 316 Chapter 25 · Disorders of Proline and Serine Metabolism Proline and Serine Metabolism Proline and serine are non-essential amino acids. Un- Serine also has important functions besides its role like all other amino acids (except hydroxyproline), pro- in protein synthesis. It is a precursor of a number of line has no primary amino group (it is termed an imino compounds (partly illustrated in . Fig. 25.2), including acid) and uses, therefore, a specific system of enzymes d-serine, glycine, cysteine, serine phospholipids, sphin- for its metabolism (. Fig. 25.1). '1-Pyrroline 5-carbo- gomyelins, and cerebrosides. Moreover, it is a major xylate (P5-C) is both the immediate precursor and the source of N5,N10-methylene-tetrahydrofolate (THF) degradation product of proline. The P5-C/proline cycle and of other one-carbon donors that are required for IV transfers reducing/oxidizing potential between cellular the synthesis of purines and thymidine. Serine is syn- organelles. Due to its pyrrolidine ring, proline (together thesized de novo from a glycolytic intermediate, 3-phos- with hydroxyproline) contributes to the structural phoglycerate and can also be synthesized from glycine stability of proteins, particularly collagen, with its high by reversal of the reaction catalyzed by serine hydro- proline and hydroxyproline content. xymethyltransferase, which thereby converts N5,N10- methylene-THF into THF (7 also Fig. 24.1). Fig. 25.1. Proline metabolism. Shaded area represents mito- (deficient in hyperprolinemia type 2); 3, P5-C synthase; 4, P5-C re- chondrial membrane. Cit, citrulline; Glu, glutamine; Orn, ornithine; ductase; 5, non-enzymatic reaction; 6, ornithine aminotransferase Pro, proline; P5-C, '1-pyrroline 5-carboxylate. 1, Proline oxidase (deficient in gyrate atrophy). Bars across arrows indicate defects (deficient in hyperprolinemia type 1); 2, P5-C dehydrogenase of proline metabolism . Fig. 25.2. Pathway of de novo serine synthesis. P, phosphate; 5, serine racemase. Glycine is synthesized from serine, but also 1, 3-phosphoglycerate dehydrogenase; 2, 3-phosphohydroxy- from other sources. Bars across arrows indicate the known defects pyruvate transaminase; 3, 3-phosphoserine phosphatase; in serine synthesis 4, serine hydroxymethyltransferase (utilizes tetrahydrofolate); 317 25 25.1 · Inborn Errors of Proline Metabolism Genetics Three disorders of proline metabolism are known: two The mode of inheritance is autosomal recessive. PRODH, in its catabolism (hyperprolinemia type I due to proline the gene encoding proline oxidase, maps to 22q11, in the oxidase deficiency and hyperprolinemia type II due to region deleted in the velocardiofacial syndrome/DiGeorge '1-pyrroline 5-carboxylate dehydrogenase deficiency) syndrome. At least 16 missense mutations have been iden- and one in its synthesis ('1-pyrroline 5-carboxylate syn- tified [4, 5]. thase deficiency). Hyperprolinemia type I is mostly con- sidered a non-disease, while hyperprolinemia type II Diagnostic Tests seems to be associated with a disposition to recurrent The diagnosis is made by amino acid analysis. Direct en- seizures. The deficiency of the proline-synthesizing zyme assay is not possible, since the enzyme is not present enzyme, '1-pyrroline 5-carboxylate synthase, which in leukocytes or skin fibroblasts. Mutation analysis is thus also intervenes in ornithine synthesis, is described in necessary to confirm the diagnosis [4]. 7 Chap. 22. Three disorders of serine metabolism are known. Treatment and Prognosis Two are in its biosynthesis: namely, 3-phosphoglycerate Since the prognosis is generally excellent, dietary treatment dehydrogenase deficiency and phosphoserine phos- is not indicated. phatase deficiency. Patients with 3-phosphoglycerate dehydrogenase deficiency are affected with congenital 1 microcephaly, psychomotor retardation and intractable 25.1.2 ∆ -Pyrroline 5-Carboxylate seizures and partially respond to L-serine or L-serine Dehydrogenase Deficiency and glycine. One patient with an association of Williams (Hyperprolinemia Type II) syndrome and phosphoserine phosphatase deficiency has been reported. Another, unexplained serine dis- Clinical Presentation order has been reported in a patient with decreased This is a relatively benign disorder, though a disposition to serine in body fluids, ichthyosis and polyneuropathy recurrent seizures is highly likely [2]. but no central nervous system manifestations. There was a spectacular response to L-serine. Metabolic Derangement Hyperprolinemia type II is caused by a deficiency of P5-C dehydrogenase, a mitochondrial inner-membrane enzyme, which intervenes in the conversion of proline into gluta- mate (. Fig. 25.1, enzyme 2). Hence, in hyperprolinemia 25.1 Inborn Errors of Proline type II, there are increased levels of proline in plasma Metabolism (usually exceeding 2000 µM; normal range 100–450 µM), urine and CSF, as well as of P5-C. Heterozygotes do not 25.1.1 Proline Oxidase Deficiency have hyperprolinemia. Evidence has been presented that (Hyperprolinemia Type I) the accumulating P5-C is a vitamin B6 antagonist (due to adduct formation) and that the seizures in this dis- Clinical Presentation order may be due at least in part to vitamin B6 inactiva- Hyperprolinemia type I is a very rare disorder, generally tion [6, 6a]. considered a benign trait but recent work suggests that it may be associated with a subset of schizophrenic patients Genetics [1–4]. This is an autosomal-recessive disease. The gene ALDH4A1 maps to 1p36. Mutations have recently been reported in Metabolic Derangement four patients (two frame-shift mutations and two missense Hyperprolinemia type I is caused by a deficiency of proline mutations) [7]. oxidase (a mitochondrial inner-membrane enzyme), which catalyses the conversion of proline into P5-C (. Fig. 25.1, Diagnostic Tests enzyme 1). Hence, in hyperprolinemia type I, there are The accumulation of P5-C in physiological fluids differen- increased levels of proline in plasma (usually not above tiates type-II and type-I hyperprolinemia. This compound 2000 µM; normal range 100–450 µM), urine and cerebro- can be qualitatively identified by its reactivity with ortho- spinal fluid (CSF). Hyperprolinemia (as high as 1000 µM) aminobenzaldehyde and can be quantitatively measured by is also observed as a secondary phenomenon in hyper- several specific assays [2]. P5-C-dehydrogenase activity can lactatemia, possibly due to inhibition of proline oxidase be measured in skin fibroblasts and leukocytes. by lactic acid. Remarkably, and in contrast with hyperpro- linemia type II, heterozygotes have hyperprolinemia. 318 Chapter 25 · Disorders of Proline and Serine Metabolism Treatment and Prognosis Diagnostic Tests The benign character of the disorder does not justify dietary The diagnosis should be suspected in patients with ence- treatment (which, in any case, would be very difficult). Sei- phalopathy comprising congenital microcephaly. Plasma zures are B6 responsive. amino acids must be measured in the fasting state (range in patients: 28–64 µM; normal range: 70–187 µM), since serine and glycine levels can be normal after feeding. In 25.2 Inborn Errors of Serine CSF, serine levels are always decreased (6–8 µM; control Metabolism range 35–80 µM), as are glycine levels, but to a lesser extent. The diagnosis is confirmed by finding a deficient activity of IV 25.2.1 3-Phosphoglycerate Dehydro- 3-phosphoglycerate dehydrogenase in fibroblasts (reported genase Deficiency residual activities from 6–22%). Clinical Presentation Treatment and Prognosis At least nine patients belonging to four families with this Treatment with L-serine has a beneficial effect on the con- disease (first reported in 1996) are known [8, 9]. They pre- vulsions, spasticity, feeding and behaviour of these patients. sented at birth with microcephaly and developed pro- Oral L-serine treatment (up to 600 mg/kg/day in six divided nounced psychomotor retardation, severe spastic tetra- doses) corrected the biochemical abnormalities in all re- plegia, nystagmus, and intractable seizures (including hyps- ported patients and abolished the convulsions in most pa- arrythmia). tients, even in those in whom many anti-epileptic treat- In addition, one patient showed congenital bilateral ment regimens had failed previously. During treatment cataract, two siblings growth retardation and hypogona- with L-serine, a marked increase in the white matter volume dism, and two other siblings megaloblastic anemia. Mag- was observed, and in some patients a progression of mye- netic resonance imaging of the brain revealed cortical and lination [12]. In two patients, convulsions stopped only af- subcortical hypotrophy and evidence of disturbed myelina- ter adding glycine (200 mg/kg/day). tion. In a girl diagnosed prenatally, because of decelerating head growth, L-serine was given to the mother at 190 mg/ Metabolic Derangement kg/day in 3 divided doses from the 27th week of gestation. The deficiency of 3-phosphoglycerate dehydrogenase, the This normalized fetal head growth and with
Recommended publications
  • Al Exposure Increases Proline Levels by Different Pathways in An
    www.nature.com/scientificreports OPEN Al exposure increases proline levels by diferent pathways in an Al‑sensitive and an Al‑tolerant rye genotype Alexandra de Sousa1,2, Hamada AbdElgawad2,4, Fernanda Fidalgo1, Jorge Teixeira1, Manuela Matos3, Badreldin A. Hamed4, Samy Selim5, Wael N. Hozzein6, Gerrit T. S. Beemster2 & Han Asard2* Aluminium (Al) toxicity limits crop productivity, particularly at low soil pH. Proline (Pro) plays a role in protecting plants against various abiotic stresses. Using the relatively Al‑tolerant cereal rye (Secale cereale L.), we evaluated Pro metabolism in roots and shoots of two genotypes difering in Al tolerance, var. RioDeva (sensitive) and var. Beira (tolerant). Most enzyme activities and metabolites of Pro biosynthesis were analysed. Al induced increases in Pro levels in each genotype, but the mechanisms were diferent and were also diferent between roots and shoots. The Al‑tolerant genotype accumulated highest Pro levels and this stronger increase was ascribed to simultaneous activation of the ornithine (Orn)‑biosynthetic pathway and decrease in Pro oxidation. The Orn pathway was particularly enhanced in roots. Nitrate reductase (NR) activity, N levels, and N/C ratios demonstrate that N‑metabolism is less inhibited in the Al‑tolerant line. The correlation between Pro changes and diferences in Al‑sensitivity between these two genotypes, supports a role for Pro in Al tolerance. Our results suggest that diferential responses in Pro biosynthesis may be linked to N‑availability. Understanding the role of Pro in diferences between genotypes in stress responses, could be valuable in plant selection and breeding for Al resistance. Proline (Pro) is involved in a wide range of plant physiological and developmental processes1.
    [Show full text]
  • The Role of Agmatine and Arginine Decarboxylase in Ischemic Tolerance After Transient Cerebral Ischemia in Rat Models
    The role of agmatine and arginine decarboxylase in ischemic tolerance after transient cerebral ischemia in rat models Jin Young Jung Department of Medicine The Graduate School, Yonsei University The role of agmatine and arginine decarboxylase in ischemic tolerance after transient cerebral ischemia in rat models Directed by Professor Seung Kon Huh The Doctoral Dissertation submitted to the Department of Medicine, the Graduate School of Yonsei University in partial fulfillment of the requirements for the degree of Doctor of Philosophy Jin Young Jung May 2007 This certifies that the Doctoral Dissertation of Jin Young Jung is approved. __________________________________ Thesis Supervisor: Seung Kon Huh __________________________________ Jong Eun Lee: Thesis Committee Member #1 __________________________________ Jin Woo Chang: Thesis Committee Member #2 __________________________________ Duck Sun Ahn: Thesis Committee Member #3 __________________________________ Ji Cheol Shin: Thesis Committee Member #4 The Graduate School Yonsei University May 2007 Acknowledgements Some may consider this short section of the thesis trivial but for me it is a chance to express my sincerest gratitude to those that I am truly thankful. First of all, I would like to express my deepest gratitude to my thesis supervisor and mentor Professor Seung Kon Huh. He has inspired me when I was troubled and always gave me a warm heart. I would also like to thank Professor Jong Eun Lee who shared her valuable time on the execution and interpretation of this study, Professor Jin Woo Chang who always inspiring me with passion and discerning insight. Professor Duck Sun Ahn whose insightful comments were essential in completing this thesis, Professor Ji Cheol Shin for the excellent suggestion for improvement in this thesis.
    [Show full text]
  • The Janus-Like Role of Proline Metabolism in Cancer Lynsey Burke1,Innaguterman1, Raquel Palacios Gallego1, Robert G
    Burke et al. Cell Death Discovery (2020) 6:104 https://doi.org/10.1038/s41420-020-00341-8 Cell Death Discovery REVIEW ARTICLE Open Access The Janus-like role of proline metabolism in cancer Lynsey Burke1,InnaGuterman1, Raquel Palacios Gallego1, Robert G. Britton1, Daniel Burschowsky2, Cristina Tufarelli1 and Alessandro Rufini1 Abstract The metabolism of the non-essential amino acid L-proline is emerging as a key pathway in the metabolic rewiring that sustains cancer cells proliferation, survival and metastatic spread. Pyrroline-5-carboxylate reductase (PYCR) and proline dehydrogenase (PRODH) enzymes, which catalyze the last step in proline biosynthesis and the first step of its catabolism, respectively, have been extensively associated with the progression of several malignancies, and have been exposed as potential targets for anticancer drug development. As investigations into the links between proline metabolism and cancer accumulate, the complexity, and sometimes contradictory nature of this interaction emerge. It is clear that the role of proline metabolism enzymes in cancer depends on tumor type, with different cancers and cancer-related phenotypes displaying different dependencies on these enzymes. Unexpectedly, the outcome of rewiring proline metabolism also differs between conditions of nutrient and oxygen limitation. Here, we provide a comprehensive review of proline metabolism in cancer; we collate the experimental evidence that links proline metabolism with the different aspects of cancer progression and critically discuss the potential mechanisms involved. ● How is the rewiring of proline metabolism regulated Facts depending on cancer type and cancer subtype? 1234567890():,; 1234567890():,; 1234567890():,; 1234567890():,; ● Is it possible to develop successful pharmacological ● Proline metabolism is widely rewired during cancer inhibitor of proline metabolism enzymes for development.
    [Show full text]
  • Amino Acid Disorders 105
    AMINO ACID DISORDERS 105 Massaro, A. S. (1995). Trypanosomiasis. In Guide to Clinical tions in biological fluids relatively easy. These Neurology (J. P. Mohrand and J. C. Gautier, Eds.), pp. 663– analyzers separate amino acids either by ion-ex- 667. Churchill Livingstone, New York. Nussenzweig, V., Sonntag, R., Biancalana, A., et al. (1953). Ac¸a˜o change chromatography or by high-pressure liquid de corantes tri-fenil-metaˆnicos sobre o Trypanosoma cruzi in chromatography. The results are plotted as a graph vitro: Emprego da violeta de genciana na profilaxia da (Fig. 1). The concentration of each amino acid can transmissa˜o da mole´stia de chagas por transfusa˜o de sangue. then be calculated from the size of the corresponding O Hospital (Rio de Janeiro) 44, 731–744. peak on the graph. Pagano, M. A., Segura, M. J., DiLorenzo, G. A., et al. (1999). Cerebral tumor-like American trypanosomiasis in Most amino acid disorders can be diagnosed by acquired immunodeficiency syndrome. Ann. Neurol. 45, measuring the concentrations of amino acids in 403–406. blood plasma; however, some disorders of amino Rassi, A., Trancesi, J., and Tranchesi, B. (1982). Doenc¸ade acid transport are more easily recognized through the Chagas. In Doenc¸as Infecciosas e Parasita´rias (R. Veroesi, Ed.), analysis of urine amino acids. Therefore, screening 7th ed., pp. 674–712. Guanabara Koogan, Sa˜o Paulo, Brazil. Spina-Franc¸a, A., and Mattosinho-Franc¸a, L. C. (1988). for amino acid disorders is best done using both South American trypanosomiasis (Chagas’ disease). In blood and urine specimens. Occasionally, analysis of Handbook of Clinical Neurology (P.
    [Show full text]
  • Yeast Genome Gazetteer P35-65
    gazetteer Metabolism 35 tRNA modification mitochondrial transport amino-acid metabolism other tRNA-transcription activities vesicular transport (Golgi network, etc.) nitrogen and sulphur metabolism mRNA synthesis peroxisomal transport nucleotide metabolism mRNA processing (splicing) vacuolar transport phosphate metabolism mRNA processing (5’-end, 3’-end processing extracellular transport carbohydrate metabolism and mRNA degradation) cellular import lipid, fatty-acid and sterol metabolism other mRNA-transcription activities other intracellular-transport activities biosynthesis of vitamins, cofactors and RNA transport prosthetic groups other transcription activities Cellular organization and biogenesis 54 ionic homeostasis organization and biogenesis of cell wall and Protein synthesis 48 plasma membrane Energy 40 ribosomal proteins organization and biogenesis of glycolysis translation (initiation,elongation and cytoskeleton gluconeogenesis termination) organization and biogenesis of endoplasmic pentose-phosphate pathway translational control reticulum and Golgi tricarboxylic-acid pathway tRNA synthetases organization and biogenesis of chromosome respiration other protein-synthesis activities structure fermentation mitochondrial organization and biogenesis metabolism of energy reserves (glycogen Protein destination 49 peroxisomal organization and biogenesis and trehalose) protein folding and stabilization endosomal organization and biogenesis other energy-generation activities protein targeting, sorting and translocation vacuolar and lysosomal
    [Show full text]
  • Amino Acid Disorders
    471 Review Article on Inborn Errors of Metabolism Page 1 of 10 Amino acid disorders Ermal Aliu1, Shibani Kanungo2, Georgianne L. Arnold1 1Children’s Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; 2Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo, MI, USA Contributions: (I) Conception and design: S Kanungo, GL Arnold; (II) Administrative support: S Kanungo; (III) Provision of study materials or patients: None; (IV) Collection and assembly of data: E Aliu, GL Arnold; (V) Data analysis and interpretation: None; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Georgianne L. Arnold, MD. UPMC Children’s Hospital of Pittsburgh, 4401 Penn Avenue, Suite 1200, Pittsburgh, PA 15224, USA. Email: [email protected]. Abstract: Amino acids serve as key building blocks and as an energy source for cell repair, survival, regeneration and growth. Each amino acid has an amino group, a carboxylic acid, and a unique carbon structure. Human utilize 21 different amino acids; most of these can be synthesized endogenously, but 9 are “essential” in that they must be ingested in the diet. In addition to their role as building blocks of protein, amino acids are key energy source (ketogenic, glucogenic or both), are building blocks of Kreb’s (aka TCA) cycle intermediates and other metabolites, and recycled as needed. A metabolic defect in the metabolism of tyrosine (homogentisic acid oxidase deficiency) historically defined Archibald Garrod as key architect in linking biochemistry, genetics and medicine and creation of the term ‘Inborn Error of Metabolism’ (IEM). The key concept of a single gene defect leading to a single enzyme dysfunction, leading to “intoxication” with a precursor in the metabolic pathway was vital to linking genetics and metabolic disorders and developing screening and treatment approaches as described in other chapters in this issue.
    [Show full text]
  • Low Proline Diet in Type I Hyperprolinaemia
    Arch Dis Child: first published as 10.1136/adc.46.245.72 on 1 February 1971. Downloaded from Archives of Disease in Childhood, 1971, 46, 72. Low Proline Diet in Type I Hyperprolinaemia J. T. HARRIES, A. T. PIESOWICZ,* J. W. T. SEAKINS, D. E. M. FRANCIS, and 0. H. WOLFF From The Hospital for Sick Children, and the Institute of Child Health, University of London Harries, J. T., Piesowicz, A. T., Seakins, J. W. T., Francis, D. E. M., and Wolff, 0. H. (1971). Archives of Disease in Childhood, 46, 72. Low proline diet in type I hyperprolinaemia. A diagnosis of Type I hyperprolinaemia was made in a 7-month-old infant who presented with hypocalcaemic convulsions and malabsorp- tion. The plasma levels of proline were grossly raised and the urinary excretion of proline, hydroxyproline, and glycine was increased; neurological development was delayed and there were associated abnormalities of the electroencephalogram, renal tract, and bones. Restriction of dietary proline at the age of 9 months resulted in a prompt fall of plasma levels of proline to normal, and a low proline diet was continued until the age of 27 months when persistence of the biochemical defect was shown. During the period of dietary treatment, growth was satisfactory, mental development improved, and the electroencephalogram, and the renal, skeletal, and intestinal abnormalities disappeared. Proline should be regarded as a 'semi-essential' amino acid in the growing infant. Hyperprolinaemia, appearing in several members balance can be maintained on a proline-free diet copyright. of a family was first described by Scriver, Schafer, (Rose et al., 1955), and therefore the amino acid is and Efron in 1961.
    [Show full text]
  • Amino Acid Chemistry
    Handout 4 Amino Acid and Protein Chemistry ANSC 619 PHYSIOLOGICAL CHEMISTRY OF LIVESTOCK SPECIES Amino Acid Chemistry I. Chemistry of amino acids A. General amino acid structure + HN3- 1. All amino acids are carboxylic acids, i.e., they have a –COOH group at the #1 carbon. 2. All amino acids contain an amino group at the #2 carbon (may amino acids have a second amino group). 3. All amino acids are zwitterions – they contain both positive and negative charges at physiological pH. II. Essential and nonessential amino acids A. Nonessential amino acids: can make the carbon skeleton 1. From glycolysis. 2. From the TCA cycle. B. Nonessential if it can be made from an essential amino acid. 1. Amino acid "sparing". 2. May still be essential under some conditions. C. Essential amino acids 1. Branched chain amino acids (isoleucine, leucine and valine) 2. Lysine 3. Methionine 4. Phenyalanine 5. Threonine 6. Tryptophan 1 Handout 4 Amino Acid and Protein Chemistry D. Essential during rapid growth or for optimal health 1. Arginine 2. Histidine E. Nonessential amino acids 1. Alanine (from pyruvate) 2. Aspartate, asparagine (from oxaloacetate) 3. Cysteine (from serine and methionine) 4. Glutamate, glutamine (from α-ketoglutarate) 5. Glycine (from serine) 6. Proline (from glutamate) 7. Serine (from 3-phosphoglycerate) 8. Tyrosine (from phenylalanine) E. Nonessential and not required for protein synthesis 1. Hydroxyproline (made postranslationally from proline) 2. Hydroxylysine (made postranslationally from lysine) III. Acidic, basic, polar, and hydrophobic amino acids A. Acidic amino acids: amino acids that can donate a hydrogen ion (proton) and thereby decrease pH in an aqueous solution 1.
    [Show full text]
  • Insights Into the Mn Binding Site in the Agmatinase-Like Protein (ALP): A
    International Journal of Molecular Sciences Article Insights into the Mn2+ Binding Site in the Agmatinase-Like Protein (ALP): A Critical Enzyme for the Regulation of Agmatine Levels in Mammals María-Belen Reyes 1, José Martínez-Oyanedel 1,*, Camila Navarrete 1, Erika Mardones 1, Ignacio Martínez 1,Mónica Salas 2, Vasthi López 3, María García-Robles 4, Estefania Tarifeño-Saldivia 1, Maximiliano Figueroa 1, David García 1 and Elena Uribe 1,* 1 Departamento de Bioquímica y Biología Molecular, Facultad de Ciencias Biológicas, Universidad de Concepción, Casilla 160-C, Concepción 4070386, Chile; [email protected] (M.-B.R.); [email protected] (C.N.); [email protected] (E.M.); [email protected] (I.M.); [email protected] (E.T.-S.); [email protected] (M.F.); [email protected] (D.G.) 2 Instituto de Bioquímica y Microbiología, Universidad Austral de Chile, Valdivia 5110566, Chile; [email protected] 3 Departamento de Ciencias Biomédicas, Universidad Católica del Norte, Coquimbo 1781421, Chile; [email protected] 4 Departamento de Biología Celular, Facultad de Ciencias Biológicas, Universidad de Concepción, Casilla 160-C, Concepción 3349001, Chile; [email protected] * Correspondence: [email protected] (J.M.-O.); [email protected] (E.U.) Received: 28 April 2020; Accepted: 5 June 2020; Published: 10 June 2020 Abstract: Agmatine is a neurotransmitter with anticonvulsant, anti-neurotoxic and antidepressant-like effects, in addition it has hypoglycemic actions. Agmatine is converted to putrescine and urea by agmatinase (AGM) and by an agmatinase-like protein (ALP), a new type of enzyme which is present in human and rodent brain tissues. Recombinant rat brain ALP is the only mammalian protein that exhibits significant agmatinase activity in vitro and generates putrescine under in vivo conditions.
    [Show full text]
  • Solutions to 7.012 Problem Set 1
    MIT Biology Department 7.012: Introductory Biology - Fall 2004 Instructors: Professor Eric Lander, Professor Robert A. Weinberg, Dr. Claudette Gardel Solutions to 7.012 Problem Set 1 Question 1 Bob, a student taking 7.012, looks at a long-standing puddle outside his dorm window. Curious as to what was growing in the cloudy water, he takes a sample to his TA, Brad Student. He wanted to know whether the organisms in the sample were prokaryotic or eukaryotic. a) Give an example of a prokaryotic and a eukaryotic organism. Prokaryotic: Eukaryotic: All bacteria Yeast, fungi, any animial or plant b) Using a light microscope, how could he tell the difference between a prokaryotic organism and a eukaryotic one? The resolution of the light microscope would allow you to see if the cell had a true nucleus or organelles. A cell with a true nucleus and organelles would be eukaryotic. You could also determine size, but that may not be sufficient to establish whether a cell is prokaryotic or eukaryotic. c) What additional differences exist between prokaryotic and eukaryotic organisms? Any answer from above also fine here. In addition, prokaryotic and eukaryotic organisms differ at the DNA level. Eukaryotes have more complex genomes than prokaryotes do. Question 2 A new startup company hires you to help with their product development. Your task is to find a protein that interacts with a polysaccharide. a) You find a large protein that has a single binding site for the polysaccharide cellulose. Which amino acids might you expect to find in the binding pocket of the protein? What is the strongest type of interaction possible between these amino acids and the cellulose? Cellulose is a polymer of glucose and as such has many free hydroxyl groups.
    [Show full text]
  • Proline Metabolism in Glucagon Treated Rats
    PROLINE CATABOLISM IN LIVER by © Michael Roland Haslett A thesis submitted to the School of Graduate Studies in partial fulfilment of the requirements for the degree of Master of Science Department of Biochemistry Memorial University of Newfoundland and Labrador 2009 St. John's Newfoundland and Labrador, Canada Abstract The goal of this work was to localize one of the enzymes involved in proline oxidation, 111-pyrroline-5-carboxylate dehydrogenase (P5CDh) and to gain an understanding of the factors affecting proline catabolism in rat liver. In this regard we performed a systematic subcellular localization for P5CDh and studied proline catabolism in response to dietary protein and exogenous glucagon. Our results indicate that P5CDh is located solely in mitochondria in rat liver. With respect to factors affecting proline catabolism we observed that rats fed a diet containing excess protein (45% casein) display a 1.5 fold increase in activity of P5CDh and proline oxidase (PO), and a 40% increase in flux through the pathway resulting in complete oxidation of proline in isolated mitochondria. We also observed that rats administered exogenous glucagon exhibit a 2 fold increase in PO activity and a 1.5 fold increase in P5CDh activity, and a 2 fold increase in flux through the pathway resulting in complete oxidation of proline in 14 14 isolated mitochondria. C02 production from C-proline in the isolated nonrecirculating perfused rat liver was also elevated 2 fold in the glucagon treated rat. We also studied the transport of proline into isolated hepatocytes and observed a 1.5 fold increase in the transport of proline in rats given exogenous glucagon.
    [Show full text]
  • Amino Acid Catalyzed Direct Asymmetric Aldol Reactions: a Bioorganic Approach to Catalytic Asymmetric Carbon-Carbon Bond-Forming Reactions
    5260 J. Am. Chem. Soc. 2001, 123, 5260-5267 Amino Acid Catalyzed Direct Asymmetric Aldol Reactions: A Bioorganic Approach to Catalytic Asymmetric Carbon-Carbon Bond-Forming Reactions Kandasamy Sakthivel, Wolfgang Notz, Tommy Bui, and Carlos F. Barbas III* Contribution from The Skaggs Institute for Chemical Biology and the Department of Molecular Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037 ReceiVed January 3, 2001 Abstract: Direct asymmetric catalytic aldol reactions have been successfully performed using aldehydes and unmodified ketones together with commercially available chiral cyclic secondary amines as catalysts. Structure- based catalyst screening identified L-proline and 5,5-dimethyl thiazolidinium-4-carboxylate (DMTC) as the most powerful amino acid catalysts for the reaction of both acyclic and cyclic ketones as aldol donors with aromatic and aliphatic aldehydes to afford the corresponding aldol products with high regio-, diastereo-, and enantioselectivities. Reactions employing hydroxyacetone as an aldol donor provide anti-1,2-diols as the major product with ee values up to >99%. The reactions are assumed to proceed via a metal-free Zimmerman- Traxler-type transition state and involve an enamine intermediate. The observed stereochemistry of the products is in accordance with the proposed transition state. Further supporting evidence is provided by the lack of nonlinear effects. The reactions tolerate a small amount of water (<4 vol %), do not require inert reaction conditions and preformed enolate equivalents, and can be conveniently performed at room temperature in various solvents. In addition, reaction conditions that facilitate catalyst recovery as well as immobilization are described. Finally, mechanistically related addition reactions such as ketone additions to imines (Mannich- type reactions) and to nitro-olefins and R,â-unsaturated diesters (Michael-type reactions) have also been developed.
    [Show full text]